ArticleCureus2025
Wolf and the Dagger: A Rare Overlap.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) and spondyloarthritis (SpA) are two distinct rheumatological disorders with different pathophysiology. The coexistence of SLE and SpA is very rare and presents unique diagnostic and therapeutic challenges. We present a case of a 28-year-old male who initially presented with inflammatory back pain and characteristic radiologic features, leading to a diagnosis of axial SpA. Subsequently, he developed malar rashes, discoid lupus erythematosus (DLE), and renal involvement. The anti-nuclear antibody (ANA) test by indirect immunofluorescence (IIF) was positive, with multiple antibody specificities on immunoblot. The overlap of SpA and SLE is rare, and a literature review identified only a few case reports. This case highlights the need for heightened clinical awareness and further research into the overlapping mechanisms of SLE and SpA, including potential genetic and immunological factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.